Skip to content

Study · Not a test of the peptide alone · 1987

2 results

[Imbalance of T lymphocyte subpopulations in patients with psoriasis and its immune correction].

Rubins AJ, Mashkilleysson AL, Merson AG, Gipsh NM

Zeitschrift fur Hautkrankheiten1 Mar 1987

PMID2954313 (opens in a new tab)PepBankPUB-02954313
Publisher pageAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone2

In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Thymalin.

  1. 01HumanNot a test of Thymalin aloneNon-randomized trialEfficacy outcome

    In psoriasis patients, complex therapy including thymalin and natrii nucleinas normalized helper/suppressor T-cell imbalance in 6 cases.

    In plain wordsIn psoriasis patients, complex therapy including thymalin and natrii nucleinas normalized helper/suppressor T-cell imbalance in 6 cases.

    Peptide
    Thymalin
    Outcome
    Not applicableTH/TS imbalance normalization
    Study

    n = 8

    Outcome group
    Immune response · Immune and inflammation

    Measurements

    Cases with normalized imbalance
    6 cases
    Complex immunocorrective therapy

    Source sentences

    Summary
    As a result of the immunocorrective therapy, the disbalance normalized in 6 cases accompanied by regression of the psoriatic rash.
    1 context sentence
    Summary · context
    In 8 patients showing a marked disbalance of TH and TS immunomodulators, thymalin and natrii nucleinas were included in the complex schedule of antipsoriatic therapy.

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

  2. 02HumanNot a test of Thymalin aloneNon-randomized trialEfficacy outcome

    In psoriasis patients, regression of rash accompanied immune normalization during complex therapy including thymalin and natrii nucleinas.

    In plain wordsIn psoriasis patients, rash regressed with immune normalization during complex therapy including thymalin and natrii nucleinas.

    Peptide
    Thymalin
    Outcome
    DecreasePsoriatic rash regression
    Study

    n = 8

    Outcome group
    Skin and hair · Skin and wound

    Source sentences

    Summary
    As a result of the immunocorrective therapy, the disbalance normalized in 6 cases accompanied by regression of the psoriatic rash.
    1 context sentence
    Summary · context
    In 8 patients showing a marked disbalance of TH and TS immunomodulators, thymalin and natrii nucleinas were included in the complex schedule of antipsoriatic therapy.

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.